LC

Lancet Capital

North America, Massachusetts, United States, Boston

Description

Lancet Capital, the first SBIC affiliated with an academic medical center, was founded in 1998 by William Golden and George Sing to create

Investor Profile

Lancet Capital has made 2 investments, with 0 in the past 12 months and 50% as lead.

Stage Focus

  • Series B (50%)
  • Seed (50%)

Country Focus

  • United States (50%)
  • Spain (50%)

Industry Focus

  • Biotechnology
  • Medical
  • Blockchain
  • Cryptocurrency
  • Fintech
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Lancet Capital frequently co-invest with?

LH
North America, New York, United States, New York
Co-Investments: 1
AC Capital
North America, Midland, Cayman Islands, Grand Cayman
Co-Investments: 1
AU21 Capital
North America, California, United States, San Francisco
Co-Investments: 1
N
North America, Virginia, United States, Charlottesville
Co-Investments: 1
Oxford Bioscience Partners
North America, Massachusetts, United States, Boston
Co-Investments: 1
EQT Life Sciences
Europe, Noord-Holland, The Netherlands, Amsterdam
Co-Investments: 1
Gray Ghost Ventures
North America, Georgia, United States, Atlanta
Co-Investments: 1
Delian Capital
Asia, Beijing, China, Beijing
Co-Investments: 1
GeneChem
North America, Quebec, Canada, Montréal
Co-Investments: 1
Chain Capital
Asia, Shanghai, China, Shanghai
Co-Investments: 1

What are some of recent deals done by Lancet Capital?

ETHA Labs

Tórtola, Castilla-La Mancha, Spain

A DeFi incubator fostering mass adoption. We're building essential DeFi infrastructure (Build) & nurturing DAO projects (Incubate).

BlockchainCryptocurrencyFinTech
SeedMar 5, 2021
Amount Raised: $1,600,000
Scion Pharmaceuticals

Boston, Massachusetts, United States

Scion Pharmaceuticals is a Biotechnology company.

BiotechnologyMedical
Series BJul 15, 2002
Amount Raised: $17,500,000